RNS & Share Price
Latest News
- Notice of results
16 September 2025 - Holding(s) in Company
11 September 2025 - Submission of new Phase III study protocol to FDA for expanded
indication of XENOVIEW
12 August 2025
About Us
Latest Annual Report
Investor Alert
Sign up for Email Alerts